ESH 2017 | New treatments for AML using inhibitors

Francesco Lo-Coco

This is an exciting time for acute myeloid leukemia (AML) treatment, with multiple new therapies being investigated currently. In this interview, Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy discusses recent research using inhibitors for the treatment of AML. This video was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH).

Share this video